Table 2.
Characteristics of all study participants (n = 201)
| Variable | Mean (SD); Median | Min‐Max |
|---|---|---|
| Age in years (N = 190) | 69.2 (9.1); 70.5 | 41‐89 |
| Years since diagnosis (N = 187) | 2.6 (1.8); 1.9 | 0.2‐11.0 |
| Variable | N | % |
| Gender (N = 196) | ||
| Male | 94 | 48.0 |
| Female | 102 | 52.0 |
| Age categories (N = 190) | ||
| 41‐50 years | 8 | 4.2 |
| 51‐60 years | 25 | 13.2 |
| 61‐70 years | 62 | 32.6 |
| 71‐80 years | 75 | 39.5 |
| >80 years | 20 | 10.5 |
| Ethnicity (N = 198) | ||
| White | 196 | 99.0 |
| Other | 2 | 1.0 |
| Marital status (N = 200) | ||
| Married/partnered | 127 | 63.5 |
| Divorced/separated | 24 | 12.0 |
| Widowed | 36 | 18.0 |
| Single | 13 | 6.5 |
| Living status (N = 198) | ||
| Alone | 57 | 28.8 |
| With partner/family/friend | 141 | 71.2 |
| Highest educational attainment (N = 197) | ||
| Primary school | 28 | 14.2 |
| High school | 122 | 61.9 |
| Higher education college | 33 | 16.8 |
| University | 14 | 7.1 |
| Employment status (N = 199) | ||
| Employed (full‐time/part‐time) | 24 (18/6) | 12.0 |
| Unemployed | 17 | 8.5 |
| Retired | 149 | 75.0 |
| Other (eg, home maker) | 9 | 4.5 |
| Annual income in £ (N = 164) | ||
| <10 000 | 64 | 39.0 |
| 10 001‐20 000 | 65 | 39.6 |
| 20 001‐50 000 | 30 | 18.3 |
| >50 000 | 5 | 3.1 |
| Deprivation index (SIMD)a (N = 185) | ||
| Fifth 1 (most deprived) | 71 | 38.4 |
| Fifth 2 | 35 | 18.8 |
| Fifth 3 | 29 | 15.7 |
| Fifth 4 | 24 | 13.0 |
| Fifth 5 (least deprived) | 26 | 14.1 |
| Smoking status (N = 195) | ||
| Ever smoker | 185 | 94.9 |
| Smoking quitter | 150 | 76.9 |
| Current smoker | 36 | 18.5 |
| Never‐smoker | 10 | 5.1 |
| Symptomatic prior to diagnosis (N = 199) | ||
| Yes | 153 | 76.9 |
| Presentation (N = 195) | ||
| GP | 151 | 77.4 |
| Emergency | 8 | 4.1 |
| Incidental | 36 | 18.5 |
| Suspected asbestos exposure (N = 197) | 36 | 18.3 |
| Disease status (N = 183) | ||
| Local | 95 | 51.9 |
| Locally advanced | 52 | 28.4 |
| Metastatic | 31 | 16.9 |
| Not staged | 5 | 2.8 |
| Treatment (N = 195) | ||
| Surgery only | 62 | 31.8 |
| Surgery in combination with other treatment | 35 | 17.9 |
| Chemotherapy | 87 | 44.6 |
| Radiotherapy | 74 | 37.9 |
| No. of comorbid illnesses (N = 188) | ||
| None | 40 | 21.3 |
| One | 83 | 44.1 |
| Two | 44 | 23.4 |
| Three or more | 21 | 11.2 |
“Local disease” is defined as any tumour that has not spread to the nodes; “Locally advanced” is defined as the spread to lymph nodes; “Metastatic” is defined as disease that is not localised and has spread to other parts of the body.
Abbreviation: SD, Standard deviation.